Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
10.35
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $16.62 million as of September 8, 2026. Its market cap has decreased by -17.86% in one year.
Market Cap
16.62M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.35
ChartMarket Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 16.62M, a decrease of -98.35%. That is a compound annual growth rate of -52.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 16.62M | -23.26% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 25.22M |
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| ZIVO Bioscience | 14.95M |
| Anebulo Pharmaceuticals | 14.63M |
| Oncotelic Therapeutics | 14.34M |
| Synlogic | 13.69M |
| Inhibitor Therapeutics | 12.87M |